Login / Signup
Ha-Ram Park
ORCID
Publication Activity (10 Years)
Years Active: 2018-2023
Publications (10 Years): 5
Top Topics
Pseudomonas Aeruginosa
Endothelial Cells
Cancer Therapy
Poor Prognosis
Top Venues
Cancer research
Oncoimmunology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ha-Ram Park
,
Anahita Shiva
,
Portia Cummings
,
Seoyeon Kim
,
Sungsoo Kim
,
Eunhyeong Lee
,
Alessandra Leong
,
Subrata Chowdhury
,
Carrie J Shawber
,
Richard D Carvajal
,
Gavin Thurston
,
Joon-Yong An
,
Amanda W Lund
,
Hee Won Yang
,
Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma.
Cancer research
(2023)
Ha-Ram Park
,
Anahita Shiva
,
Portia Cummings
,
Seoyeon Kim
,
Sungsoo Kim
,
Eunhyeong Lee
,
Alessandra Leong
,
Subrata Chowdhury
,
Carrie J Shawber
,
Richard D Carvajal
,
Gavin Thurston
,
Joon-Yong An
,
Amanda W Lund
,
Hee Won Yang
,
Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma.
Cancer research
(2023)
Ha-Ram Park
,
Anahita Shiva
,
Portia Cummings
,
Seoyeon Kim
,
Sungsoo Kim
,
Eunhyeong Lee
,
Alessandra Leong
,
Subrata Chowdhury
,
Carrie J Shawber
,
Richard D Carvajal
,
Gavin Thurston
,
Joon-Yong An
,
Amanda W Lund
,
Hee Won Yang
,
Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma.
Cancer research
(2023)
Ha-Ram Park
,
Anahita Shiva
,
Portia Cummings
,
Seoyeon Kim
,
Sungsoo Kim
,
Eunhyeong Lee
,
Alessandra Leong
,
Subrata Chowdhury
,
Carrie J Shawber
,
Richard D Carvajal
,
Gavin Thurston
,
Joon-Yong An
,
Amanda W Lund
,
Hee Won Yang
,
Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma.
Cancer research
(2023)
Seong-Ho Kang
,
Bhumsuk Keam
,
Yong-Oon Ahn
,
Ha-Ram Park
,
Miso Kim
,
Tae Min Kim
,
Dong-Wan Kim
,
Dae Seog Heo
Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma.
Oncoimmunology
8 (1) (2018)